Novartis' (NOVN SW) Kisquali gets FDA sNDA approval
Microsoft (MSFT) is introducing Microsoft Frontier Company, a new operating business focused on delivering Frontier Transformation through AI for our customers around the world.
Iran Minister of Agriculture says if US does not meet our conditions, purchases will be made from other sources
Novartis' (NOVN SW) Kisquali gets FDA sNDA approval
US DoE has proposed an update to energy conservation standards for household appliances
Explosions reported in Erbil, Northern Iraq, reports Tasnim
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
Related headlines
- [MARKET ANALYSIS] European bourses hit amid higher energy prices; NOVN SW on track for its biggest daily loss since Covid 20201 day ago
- European Equity pre-Market Summary - 9th September 2026: European bourses are indicative of a slightly softer open; Inditex reports poor results3 hours ago
- European Movers: Airbus (AIR FP) -0.7%, Schneider Electric (SU FP) -0.9%, Société Générale (GLE FP) -1.6%, Infineon (IFX GY) -1.9%, Novartis (NOVN SW) -9%, 1 day ago
- European Equity pre-Market Summary - 8th September 2026: Novartis does not meet Phase 3 primary endpoint; European equity futures indicative of a slightly lower open, as energy picks up1 day ago
- US Market Wrap: Stocks fall and crude gains amid escalating geopolitics 13 hours ago
- Newsquawk European Market Wrap - 8th September 202619 hours ago
- Newsquawk Daily European Equity Opening News - 9th September 20264 hours ago
- US EQUITY OPEN: US indices open in the red amid downbeat risk tone after Labor Day holiday19 hours ago
- US PREMARKET MOVERS: NVS, TSLA, UNFI, UBER, INTC, RGTI, AMGN, PTON20 hours ago
- Merck (MRK) veteran and psychedelics developer tapped for top FDA job13 hours ago
- Santander (SAN SM) files to sell USD-denominated 3-parter21 hours ago
- AstraZeneca (AZN LN) says Phase III tozorakimab data in COPD showed a 29%-34% reduction in exacerbations21 hours ago
- Bristol Myers Squibb (BMY) said a trial met its primary endpoint of overall response rate and key secondary endpoint of complete response rate in a heavily pretreated patient population exposed to a prior BCMA-targeted therapy22 hours ago
- US BROKER MOVES: INTC upgraded at Northland; PTON downgraded at MS21 hours ago
- Additional European Equity News - 8th September 20261 day ago
- FDA notes FI recalls dog supplements due to possible salmonella contamination16 hours ago
- [MARKET ANALYSIS] JPY continues to gain after daring commentary from US Treasury Sec. Bessent27 min ago
- Uber (UBER) is looking to raise around EUR 4bln from its EUR bond sale45 min ago
- [MARKET ANALYSIS] European bourses under pressure as renewed US-Iran strikes drive energy higher; ITX SM hit despite mixed earnings while FORTUM FH surges on GOOGL deal46 min ago
- [MARKET UPDATE] Brent front-month crosses back above USD 100/bbl for the first time since July 24th; newsflow light but geopolitical tensions remain high following the recent US-Iran retaliatory strikes2 hours ago
The whole workspace, free to try.
Try it free